Back to search

Article

Predicting MammaPrint Recurrence Risk from Breast Cancer Pathological Images Using a Weakly Supervised Transformer

2025-04-29

Abstract excerpt

Recurrence related to poor prognosis is a leading cause of mortality in patients with breast cancer (BC). The MammaPrint (MP) genomic assay is designed to stratify recurrence risk and evaluate chemotherapy benefits for early-stage HR+/HER2- BC patients. However, MP fails to reveal spatial tumor morphology and is limited by high costs. In this study, we establish a BC MP cohort and develop CPMP, a weakly supervised...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ab5a7b01-807f-5fc4-9eb9-0588521c89b8
DOI
10.1101/2025.04.26.648504
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Predicting MammaPrint Recurrence Risk from Breast Cancer Pathological Images Using a Weakly Supervised TransformerDOI 10.1101/2025.04.26.648504
Select a neighboring publication to make it the new centre.